MPH.L Share News (MPH)
MPH Share
MPH Share
MPH Share
MPH Share
MPH
MPH Share
MPH Broker
MPH Directors
MPH Financial
MPH
MPH Short
MPH
(Alliance News) - Mereo BioPharma Group PLC on Tuesday posted a slightly narrowed loss for the first half of 2019 on a gain from its OncoMed Pharmaceuticals Inc acquisition, as well as lower in at
Read more(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Corporate Development John Richard, all purchased
Read more(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was
Read moreThursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday reported positive six-month data for its anti-sclerostin antibody, BPS-804, in the treatment of adult patients with osteogenesis were
Read more
(Sharecast News) - Clinical stage biopharmaceutical company Mereo BioPharma Group announced encouraging six-month data from the open label arm of its phase 2b dose-ranging clinical study in adults with type I, III or IV osteogenesis imperfecta (OI) treated with BPS-804 ('setrusumab'), or the 'ASTEROID' study, on Thursday.
Read moreLONDON (Alliance News) - Mereo Biopharma PLC said Thursday that Non-Executive Director Peter Bains purchased around GBP42,750 in stock in a deal on Tuesday.Bains bought 47,500 shares at a
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Monday said its loss narrowed in 2018 following the completion of several product trials.The clinical stage biopharmaceutical company a
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Tuesday said its all-stock merger with OncoMed Pharmaceuticals Inc is now complete.OncoMed's shareholders approved the deal on last
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday said OncoMed Pharmaceuticals Inc shareholders have approved the merger of the two companies.Mereo BioPharma, a clinical stage
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC said on Monday it has concluded an end of Phase Two meeting with the US Food & Drug Administration regarding acumapimod as a treatment for of
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Friday said it has now received support agreements in respect of 21.1% of OncoMed Pharmaceuticals Inc's shares and expects to complete the
Read more(Sharecast News) - Clinical-stage biopharmaceutical company Mereo BioPharma Group updated the market on its proposed combination with OncoMed Pharmaceuticals on Friday, which it said should close in the second quarter of 2019.
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC said Friday it has requested the withdrawal of its US IPO application as it continues to work on its business combination with US pharmaceutical
Read moreLONDON (Alliance News) - Mereo BioPharma Group PLC on Monday announced the immediate departure of founding board director Frank Armstrong prior to Mereo's combination with US firm OncoMed was
Read more